Pesquisa

Edição
Título
Autores
New approaches to staging and treatment of primary endometrial cancer
Bakhidze E., Belyaeva A., Berlev I.
Prevalence of chronic kidney disease among cancer patients
Трофимцева Т., Yarovoy S., Gritskevich A.
Cardiac toxicity of fluoropyrimidines in the treatment of solid gastrointestinal tumors
Bogatyreva L., Besova N., Yunayev G., Kurmukov I., Obarevich E., Gavrilova D., Egorova A., Lepkova N., Tryakin A.
TIME COURSE AND PROGNOSIS OF BENIGN AND MALIGNANT TUMORS OF THE FEMALE REPRODUCTIVE SYSTEM ON THE BACKGROUND OF COMORBID CONDITIONS
Vertkin A., Kozlova O., Khashukoeva A., Vertkin A., pl?midmagidsid h., Khashukoyeva A.
Assessing the risk of recurrence of luminal HER2-negative breast cancer and the possibility of intensifying adjuvant hormonal therapy to reduce the risk of progression
Gordeeva O.
Non-small lung cancer. Expanding therapeutic opportunities: pembrolizumab in a number of malignant tumors
Gutorov S., Borisova E., Abramov M., Lud A., Arutyunyan E.
Klinicheskiy sluchay uspeshnogo lecheniya erilibulinom metastaticheskogo raka molochnoy zhelezy
Limareva S., Laytsan K., Stroyakovskiy D., Demidova I., Gorbunova V.
PARP inhibitors in a personalized approach to the treatment of castration-resistant prostate cancer: clinical case
Gritskevich A., Byteman T., Monakov D., Rusakov I., Mishugin S.
Evaluation of long-term results of treatment of patients with residual tumors (including those with minimal forms of ypT1abN0), with pathomorphological complete response (pCR) after neoadjuvant systemic therapy, with primary minimal breast cancer (pT1abN0M0)
Pesotsky R., Semiglazov V., Krivorotko P., Tabagua T., Zernov K., Emelyanov A., Semiglazova T., Amirov N., Mortada V., Ulrikh D., Levchenko V., Rychagov K., Zirov K., Evseev V.
The role of alpelisib in the treatment of PIK3CA - a mutated breast cancer
Semiglazov V., Krivorotko P., Komyakhov A., Semiglazova T., Gigolaeva L., Tabagua T., Kazantseva M., Tergoeva A., Ulrikh D., Chervyak M., Klimenko V., Amirov N., Zhiltsova E., Semiglazov V.
The effect of drug therapy and cetuximab on the mutational status of the KRAS gene in patients with squamous cell carcinoma of the tongue and oral floor mucosa
Lyanova A., Vladimirova L., Kutilin D., Abramova N., Popova I., Tikhanovskaya N., Teplyakova M., Novoselova K., Myagkova V., Alieva F., Ryadinskaya L.
Experience of the use of ixabepilone in polychemotherapy regimens for disseminated triple-negative breast cancer
Glazkova E., Frolova M., Menshikov S., Stenina M.
Perspektivy primeneniya kapsul vinorelbina v sovremennoy onkologii
Gutorov S., Stepanchenko M., Lichinitser M.
Eribulin – novyy mikrotrubochkovyy ingibitor dlya lecheniya metastaticheskogo raka molochnoy zhelezy
Stenina M.
Efficacy of ramucirumab in the second-line treatment of patients with disseminated gastric cancer in routine clinical practice in Russia (RAMSELGA observational study)
Besova N., Titova T., Tryakin A., Artamonova E., Stroyakovsky D., Perminova E., Yukalchuk D., Ponomarenko D., Belyak N., Orlova R., Teletaeva G., Ratner E., Mochalova A., Zhabina A., Gamayunov S., Smolin A., Povyshev A., Andrievskikh M., Stilidi I.
Opyt kombinirovannogo lecheniya bol'nykh kolorektal'nym rakom s izolirovannymi metastazami v pecheni
Chernoglazova E., Vyshinskaya G., Sagaydak I., Rotobel'skaya L., Vorontsova K.
Nasopharyngeal cancer. ESMO 2024 news
Golubev P., Bolotina L., Kuzmina E., Pokataev I., Golubeva A., Kyanzhin E., Kuzmin V., Galkin V.
Modern approaches to the treatment of muscle-invasive bladder cancer
He Mingze -., Zeng Zitong -.
Rol' aflibertsepta v lechenii metastaticheskogo kolorektal'nogo raka
Meshcheryakov A.
Rol' gistologicheskogo i molekulyarnogo analiza v vybore metoda lecheniya nemelkokletochnogo raka legkogo pozdnikh stadiy
Vladimirova L., Kit O., Sholokhova E.
Algorithm for diagnostics and systemic therapy of metastatic hormone-sensitive HER2-negative breast cancer
Dashyan G., Olchonova A., Dzhelyalov E., Akhmedov R., Sereda O., Vats A., Zhurov A., Shaikhelislamova L., Pushkaruk G., Belousov A.
Abemacyclib is a unique representative of the class of CDK4/6 inhibitors in the treatment of HR+/HER2- metastatic breast cancer
Grechukhina K., Vorontsova K., Kuko T., Prosvirnov A., Ganshina I., Lubennikova E., Kolyadina I., Zhukova L.
Structural and functional changes in the thyroid gland in the early and late periods after radiation therapy
Amergulov I., Pavlova M., Sych Y., Zhuravleva Y., Dolov M., Berdyklychev M., Dobrokhotova V., Sannikova E., Trofimova O., Orlova M., Kuznetsova D., Bychkova N., Zaitseva N., Kandakova E., Sotnikov V., Ryzhkova E., Fadeev V.
The role of cyclin-dependent kinase inhibitors in adjuvant therapy of breast cancer
Semiglazov V., Krivorotko P., Bekkeldiyeva N., Komyakhov A., Emelyanov A., Gorina A.
TREATMENT OF NON-SMALL CELL LUNG CANCER: THE NEXT STEP
Borisova E., Gutorov S., Abramov M.
Osobennosti klinicheskogo techeniya invazivnogo dol'kovogo raka molochnoy zhelezy
Borisova E., Vyshinskaya G., Gutorov S., Stepanchenko M.
Avastin (bevacizumab) in the treatment of tumors of the stomach and pancreas
Semenov N.
Neoadjuvant and postneoadjuvant treatment for triple negative breast cancer
Semiglazov V., Dzhelyalova M., Tseluyko A., Pesotsky R., Bessonov A., Semiglazova T.
Novye vozmozhnosti ispol'zovaniya targetnoy terapii v lechenii nekotorykh solidnykh opukholey (po materialam ESMO-2014)
Dobrova N.
CAPECITABINE AND FLUOROURACIL IN THE TREATMENT OF COLORECTAL CANCER AND GASTRIC CANCER: ANALYSIS OF DIRECT COMPARATIVE STUDIES
Fedyanin M., Tryakin A., Fedyanin M., Tryakin A.
Potentials for endoscopic and magnetic resonance diagnostic methods in assessing the radicality of chemoradiotherapy in patients with rectal cancer
Salimova A., Makarova M., Besova N., Kuvshinov Y., Karasev I.
Clinical experience with the use of combination drug therapy in the first line treatment of metastatic non-small cell lung cancer
Ivanova F., Nikolaeva T., Spiridonova N., Afanasyeva L., Nikiforov P., Zharnikova T.
GSTT1 and GSTM1 deletion polymorphism as a predictor of response to hormonal therapy for breast cancer
Gulian I., Bystritskaya E., Otstavnykh N., Khudchenko E., Eliseeva E., Apanasevich V., Isaeva M.
Ixabepilone in the treatment of breast cancer
Semiglazov V., Krivorotko P., Semiglazova T., Komyakhov A., Tabagua T., Kazantseva M., Zhiltsova E., Ulrikh D., Chervyak M., Tergoeva A., Klimenko V., Semiglazov V.
Diagnosis of HPV-associated cervical diseases in postmenopausal women. Problems and solutions
Dovletkhanova E.
Systemic alpha-radiotherapy with radium-223 (Xofigo) in patients with metastatic castration-resistant prostate cancer (mCRPC). Clinical experience of using the drug in Sverdlovsk Regional Oncological Dispensary, Yekaterinburg
Kulakova A., Bentsion D., Elishev V., Vetrov V.
Sentinel lymph node scintigraphy in breast cancer. Own experience
Afanasyeva N., Vazhenin A., Trofimchuk L., Chvanova K.
A unique case of colon cancer metastasis treatment. A case from practice
Khakimova G., Islamov F., Khakimov G.
Abemacyclib - new options for the treatment of hormone-positive metastatic breast cancer with CDK4/6 inhibitors
Semiglazova T., Volynshchikova O., Semiglazov V., Klimenko V., Brish N., Alekseeva Y., Klyuge V., Krutov A., Paltuev R., Kasparov B., Krivorotko P., Semiglazov V.
Primary multiple colonic tumors of various genetic characteristics in a patient with familial adenomatous polyposis: description of the clinical case
Gutorov S., Borisova E., Ivanova K., Manukyan M., Abdulkhuseinova S.
A prospective non-randomized trial: the use of platinum-containing chemotherapy with mitomycin for relapses of BRCA1-associated ovarian cancer
Kotiv K., Yakovleva M., Sokolenko A., Gorodnova T., Ivantsov A., Nekrasova E., Smirnova O., Sidoruk A., Bondarev N., Meshkova I., Mikaya N., Petrik S., Urmancheeva A., Ulrikh E., Protsenko S., Belyaev A., Imyanitov E., Berlev I.
Prognostic and predictive values of the PIK3CA gene mutation in patients with breast cancer
Semiglazova T., Sorokina I.
RAMUCIRUMAB IN A COMBINATION WITH IRINOTECAN-BASED TWO-COMPONENT THERAPY REGIMEN AS THE SECOND LINE FOR THE TREATMENT OF DISSEMINATED GASTRIC CANCER. CASE REPORT
Titova T., Besova N., Gorbunova V., Fedenko A., Malikhova O.
GONADOTROPIN-RELEASING HORMONE AGONISTS-INDUCED OVARIAN SUPPRESSION IN EARLY BREAST CANCER
Semiglazova T., Berlev I., Ulrikh E., Semiglazov V., Protasova A., Brish N., Korobeynikova E., Alekseeva Y., Filatova L., Semenova A., Latipova D., Teletaeva G., Tkachenko E., Klimenko V., Dashyan G., Protsenko S., Paltuev R., Urmancheeva A., Krivorotko P., Semiglazov V.
Prognostic values of the presence of disseminated tumor cells in the bone marrow in patients with disseminated stomach cancer before start of treatment with antitumor drugs
Besova N., Obarevich E., Davydov M., Beznos O., Tupitsyn N.
ONCOMODULATING EFFECT OF CYTOMEGALOVIRUS IN BLADDER CANCER: MYTH OR REALITY?
Loran O., Sinyakova L., Gundorova L., Kosov V., Kosova I., Pogodina I., Kolbasov D.
WHETHER PRIMARY TUMOR LOCALIZATION IS IMPORTANT FOR THE PREDICTION OF DRUG TREATMENT OF METASTATIC COLON CANCER?
Dobrova N., Borisova E., Gutorov S., Abramov M.
ROLE OF NEW ANTIANGIOGENIC DRUGS IN THE SECOND-LINE TREATMENT OF NON-SMALL-CELL LUNG CANCER
Semenova A., Protsenko S., Novik A., Latipova D., Teletayeva G., Semiglazova T.
MODERN POSSIBILITIES OF MEDICAL TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BLADDER CANCER
Vorontsova K., Zhukova L.
Struktura slizistoy obolochki zheludka u bol'nykh rakom zheludka v Respublike Khakasiya
Tsukanov V., Kasparov E., Butorin N., Shtygasheva O., Vasyutin A., Amel'chugova O., Tonkikh Y., Bronnikova E.
KOMPLEKSNAYa TERAPIYa HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
Semiglazov V., Semiglazov V., Nikolaev K., Dashyan G., Paltuev R.
Novye metody terapii v lechenii kastratsionnorezistentnogo raka predstatel'noy zhelezy
Sokov D.
SOVREMENNYE PODKhODY K LEKARSTVENNOY TERAPII BOL'NYKh METASTATIChESKIM KASTRATsIONNO-REFRAKTERNYM RAKOM PREDSTATEL'NOY ZhELEZY
Kaprin A., Alekseev B., Nyushko K., Kalpinskiy A.
Znachenie molekulyarnykh markerov pri vybore neoad\"yuvantnoy khimioterapii mestno-rasprostranennogo raka molochnoy zhelezy
Semiglazova T., Semiglazov V., Filatova L., Krivorot'ko P., Klimenko V., Ivanov V., Novikov S., Gershanovich M., Imyanitov E., Semiglazov V.
NASTOYaShchEE I BUDUShchEE TARGETNOY TERAPII V PERVOY LINII LEChENIYa RAKA YaIChNIKOV
Tyulyandina A.
A new approach to the overcoming resistance to hormone therapy of breast cancer
Semiglazova T., Semiglazov V., Filatova L., Krivorot'ko P., Klimenko V., Gershanovich M., Semiglazov V.
Khronicheskiy gastrit: kak preodolet' kompleks neopredelennosti?
Khomeriki N., Khomeriki S.
SKRININGOVOE OBSLEDOVANIE BOL'NYKh S KhRONIChESKIMI ZABOLEVANIYaMI PEChENI DLYa VYYaVLENIYa RANNIKh STADIY GEPATOTsELLYuLYaRNOGO RAKA
Zinatulin D., Trandofilov M., Shevchenko V., Vedeneev A.
TARGETED THERAPY AFTER PROGRESSION OF HER-2-POSITIVE BREAST CANCER
Tat'yana Y., Semiglazov V., Larisa V., Chubenko V., Nikita V., Fedor V., Latipova D., Mikhail L., Semiglazova T., Semiglazov V., Filatova L., Chubenko V., Brejnev N., Moiseenko F., Latipova D., Gershanovich M.
RISK-ASSOCIATED THERAPY OF MUSCULAR-NONINVASIVE BLADDER CANCER
Golovashchenko M., Rusakov I., Golovaschenko M., Rusakov I.
MAINTENANCE THERAPY IN STAGES IIIB-IV NON-SMALL-CELL LUNG CANCER
Gutorov S., Borisova Y., Gutorov S., Borisova E.
Prophylaxis of cervical cancer
Prilepskaya V., Bebneva T., Prilepskaya V., Bebneva T.
Analysis of pharmacotherapy in patients with HR+HER2- metastatic breast cancer with PIK3CA mutations in real clinical practice
Fateeva A., Eliseeva E., Apanasevich V., Zaemskaya A.
Frequency and spectrum of PIK3CA mutations in hormone-dependent HER2-negative breast cancer: a single-center experience
Romashkina N., Klishina M., Karabina E.
Prospective randomized phase III trial comparing FOLFIRINOX and mFOLFOX6 as first-line treatment for patients with disseminated gastric cancer: interim assessment of tolerability and toxicity
Gavrilova D., Besova N., Obarevich E., Makiev G., Tryakin A., Stilidi I.
Type 3 diabetes mellitus: is there a chance to become famous?
Morgunov L.
Hope or error: can combinations of EGFR tyrosine kinase inhibitors and other drugs replace monotherapy?
Moiseenko F.
The use of panitumumab in the treatment of chemoresistant metastatic sigmoid colon adenocarcinoma: a clinical case
Protsenko S., Teletaeva G., Degtyareva E., Semenova A., Latipova D., Novik A.
The combination of gemcitabine and nab-paclitaxel in patients with locally advanced and advanced pancreatic cancer
Vladimirova L., Abramova N., Popova I., Novoselova K., Tikhanovskaya N., Ryadinskaya L., Lyanova A., Myagkova V., Teplyakova M., Storozhakova A., Kalabanova E., Samaneva N., Kabanov S., Svetitskaya Y., Tishina A., Strakhova L., Yezhova M.
Pembrolizumab in the treatment of patients with non-small cell lung cancer and metastatic brain lesion: a clinical review
Vakhabova Y., Kolomeytseva A., Kalinin D., Kozak E., Fedenko A.
COMPARATIVE EVALUATION OF THE PROLIFERATIVE ACTIVITY OF CELLS OF KERATOACANTHOMA AND SQUAMOUS CELL SKIN CANCER
Kuntsevich Z., Gurevich L.
PROGNOSTIC SIGNIFICANCE OF THE E-CADHERIN EXPRESSION LEVEL IN PRIMARY TUMORS OF THE COLON IN PATIENTS WITH METASTATIC COLORECTAL CANCER, RECEIVED NEW CHEMOTHERAPY REGIMEN BASED ON TRIPLE COMBINATION: IRINOTECAN+OXALIPLATIN+CONTINUOUS-INFUSION 5-FLUOROURACIL AS A FIRST-LINE TREATMENT
Darenskaya A., Dobrova N., Khochenkov D., Stepanova E.
PD-L1 EXPRESSION IN BLADDER CANCER AGAINST THE BACKGROUND OF CHRONIC HERPESVIRUS INFECTION: RESULTS OF A PILOT STUDY
Kosova I., Loran O., Sinyakova L., Gundorova L., Kosov V., Pogodina I., Kolbasov D.
New possibilities of the treatment of breast cancer: microtubule inhibitors
Semiglazov V., Dashyan G., Krivorotko P., Paltuev R., Donskikh R., Semiglazova T., Zernov K., Gigolaeva L., Apollonova V.
Basic mechanisms of resistance to egfr tyrosine kinase egfrinhibitors
Sakaeva D., Gordiev M.
Eradication of Helicobacter pylori infection as a strategy for the prevention of stomach cancer: statements of MaastrichT-V consensus (2015)
Mayev I., Andreev D., Samsonov A., Dicheva D., Zaborovsky A., Partsvania-Vinogradova E.
PROSTATE-SPECIFIC ANTIGEN AS A CRITERION OF PROSTATE CANCER PROGRESSION AFTER RADICAL PROSTATECTOMY
Varlamov I., Varlamov S., Lazarev A.
APPLICATION OF REPLACEMENT THERAPY WITH PANCREATIN PREPARATIONS IN PATIENTS WITH PANCREATIC CANCER
Kucheryavy Y., Andreev D.
PLACE OF LAPATINIB IN THE THERAPY OF HER2-POSITIVE BREAST CANCER
Zhukova L., Ganshina I., Zaitsev V., Stepanchenko M.
Prognoz bol'nykh kolorektal'nym rakom pri ozhirenii
Solodkiy V., Chkhikvadze V., Stanoevich U., Dekhissi E.
H. PYLORI-INFEKTsIYa: SOVREMENNYE REKOMENDATsII PO DIAGNOSTIKE I LEChENIYu
Gratsianskaya A.
PERSPEKTIVY PRIMENENIYa S-1 V LEChENII BOL'NYKh RAKOM ZhELUDKA
Lud A., Abramov M., Meshcheryakov A.
NOVYE PERSPEKTIVNYE PREPARATY DLYa LEChENIYa HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
Gorbunova V.
ROL' IMMUNOKON\"YuGATOV V TARGETNOY TERAPII ZLOKAChESTVENNYKh OPUKhOLEY
Semiglazov V., Dashyan G., Semiglazova T., Paltuev R., Zernov K., Pen'kov K., Grechukhina I., Semiglazov V.
Combined treatment of colorectal cancer patients with liver metastases
Polyakov A., Podluzhnyy D., Mamontov K., Borodin D., Patyutko Y.
Opyt primeneniya trastuzumaba v respublike Bashkortostan
Sakaeva D., Kunafina R., Popova E.
PRIMARY PREVENTION OF CERVICAL CANCER: PROGRESS AND PROSPECTS
Prilepskaya V., Bebneva T., Prilepskaya V., Bebneva T.
ADJUVANT CHEMOTHERAPY FOR COLON CANCER
Fedyanin M., Tryakin A., Tyulyandin S., Fedyanin M., Tryakin A., Tyulyandin S.
XELODA IN THE TREATMENT OF METASTATIC COLORECTAL CANCER
Dobrova N., Dobrova N.
Efficacy and safety of testosterone drugs in the treatment of hypogonadism in men
Gamidov S., Ovchinnikov R., Pavlovichev A., Tkhagapsoeva R., Gamidov S., Ovchinnikov R., Pavlovichev A., Thagapsoeva R.
Approaches to the diagnosis and treatment of patients with stage III–IV non-small cell lung cancer in Russia. Preliminary results of a retrospective multicenter non-interventional observational study
Reutova E., Laktionov K.
Trastuzumab deruxtecan in the treatment of breast cancer
Semiglazov V., Krivorotko P., Bekkeldieva N., Gorina A., Komyakhov A., Paltuev R., Tabagua T., Ereshenko S.
Reconstructive plastic surgery of the breast using autogenous tissue. Historical aspects
Khakimova S., Zikiryakhodzhaev A., Kaprin A., Khakimova G., Onofriychuk I., Rasskazova E., Sukhotko A., Vlasova M., Bosieva A., Tokaev V.
Pelvic extrusion in patients with cervical cancer: clinical experience
Khakimov G., Khakimova G., Musurmonov K., Khakimova S., Orifjonova G.
Multiple thyroid carcinoma and other long-term endocrine consequences of chemoradiotherapy for medulloblastoma: a clinical case
Khruleva Y., Amergulov I., Likhodey N., Dzyuba A., Sych Y., Pavlova M.
Will our clinical practice change with the availability of new diagnostic methods, drug therapy and assessment of its effectiveness? Clinical case: hormone receptor-positive, HER2-negative metastatic breast cancer
Konstantinova M., Kuzina L.
Olaparib -modern approach to the treatment of BRCA-associated HER2-negative metastatic breast cancer. Clinical experience
Lubennikova E., Zhukova L., Gordeeva O., Drobot N., Kuznetsov A., Ganshina I.
The effectiveness of detoxification specialized nutrition for oncological diseases
Pilat T., Khanferyan R.
Experience of using a combination of gemcitabine and carboplatin in the treatment of metastatic collecting duct (Bellini) carcinoma
Sakaeva D., Kunafina R., Almukhametova G., Akchulpanov T.
Treatment of residual breast cancer
Ereschenko S., Semiglazov V., Krivorotko P., Dashyan G., Smirnova V., Komyakhov A., Gigolaeva L., Zhiltsova E.
1 - 100 de 288 resultados 1 2 3 > >> 
Dicas:
  • Palavras-chave são sensíveis a maiúsculas
  • Preposições e conjunções ingleses são ignoradas
  • Busca é feita por todos os palavras-chave (agente AND experimentador) por omissão
  • Use OR para pesquisar um termo exato, ex.: educação OR formação
  • Use parênteses para criar frases complexas, ex.: arquivo de ((revistas OR conferências) NOT teses)
  • Para pesquisar uma frase precisa use aspas duplas, ex.: "investigações científicas"
  • Exclua uma palavra utilizando o sinal - (hífen) ou operador NOT; ex.: concurso-de beleza ou concurso NOT de beleza
  • Use * como caractere-coringa, ex.: científic* recuperará as palavras "científico", "científicos", etc.